세계의 척주 후만증 치료 시장 보고서(2025년)

Kyphoscoliosis is a spinal condition characterized by abnormal forward curvature (kyphosis) and sideways curvature (scoliosis) of the spine, leading to postural and respiratory problems. The treatment involves medical interventions and therapies aimed at managing and correcting the spinal deformity, improving posture, reducing pain, and preventing further spinal curvature.

The main types of kyphoscoliosis include postural kyphosis, Scheuermann's kyphosis, congenital kyphosis, and kyphoscoliosis. Postural kyphosis refers to the rounding or hunching of the back, typically affecting teenagers and young adults. Treatment options for kyphoscoliosis encompass medications, surgery, and bracing, and these are implemented by hospitals, clinics, and ambulatory surgical centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The kyphoscoliosis treatment market research report is one of a series of new reports from The Business Research Company that provides kyphoscoliosis treatment market statistics, including kyphoscoliosis treatment industry global market size, regional shares, competitors with a kyphoscoliosis treatment market share, detailed kyphoscoliosis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the kyphoscoliosis treatment industry. This kyphoscoliosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The kyphoscoliosis treatment market size has grown strongly in recent years. It will grow from $3.08 billion in 2024 to $3.25 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to exploration of regenerative medicine, genetic research contributions, telemedicine and remote monitoring, advancements in rehabilitation programs.

The kyphoscoliosis treatment market size is expected to see strong growth in the next few years. It will grow to $4.05 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to personalized treatment approaches, expansion of biomechanical research, remote monitoring and telehealth services, continued genetic research. Major trends in the forecast period include advanced surgical techniques, innovative bracing technologies, customized treatment plans, adoption of 3D printing, pain management innovations.

The forecast of 5.7% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for the U.S. by restricting access to custom spinal rods and vertebral body tethering systems imported from Switzerland and Japan, potentially compromising corrective surgeries and increasing spinal care unit costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing number of spinal cord injuries is anticipated to drive the expansion of the kyphoscoliosis treatment market. Spinal cord injuries refer to any damage, trauma, or harm to the spine's components, including the vertebrae, intervertebral discs, ligaments, muscles, nerves, and other supportive structures, which can lead to the development of kyphoscoliosis and alterations in spinal alignment. Treating kyphoscoliosis caused by spinal cord injuries involves a holistic approach, including orthopedic evaluation, physical therapy, bracing, possible surgery, pain management, and a multidisciplinary healthcare team focused on patient education and personalized care plans. For example, in February 2022, according to the Alabama Department of Public Health, a US-based state agency, the ATR reported 3,817 neurological injuries involving the head and spinal cord in 2022, compared to 4,734 cases in 2021. As a result, the increasing number of spinal cord injuries is fueling the growth of the kyphoscoliosis treatment market.

The rise in telemedicine usage is expected to further drive the growth of the kyphoscoliosis treatment market. Telemedicine refers to healthcare services delivered remotely through telecommunications technologies, such as videoconferencing, phone calls, and digital messaging. It enables patients to consult with orthopedic specialists and spine surgeons without needing to travel to healthcare facilities, which is particularly beneficial for individuals with kyphoscoliosis who may face physical challenges. For example, in February 2023, Rock Health, a US-based non-profit, reported that 80% of survey respondents had used telemedicine at some point in 2022, up from 72% in 2021. Thus, the increased use of telemedicine is contributing to the growth of the healthcare transportation service market.

The increasing incidence of genetic disorders is expected to be a significant catalyst for the growth of the kyphoscoliosis treatment market. Genetic disorders, stemming from abnormalities or mutations in an individual's DNA, often involve spinal curvature abnormalities requiring kyphoscoliosis treatment. The prevalence of genetic conditions in children is estimated to be 1 in 25 in the UK, affecting over 2.4 million individuals. The multidisciplinary treatment approach, encompassing various strategies such as beta-blocker therapy, physical therapy, and orthopedic surgeon supervision, underlines the pivotal role of kyphoscoliosis treatment in managing genetic disorders and contributes to market growth.

Leading companies in the kyphoscoliosis treatment market are developing innovative products, such as the MARVEL Growing Rod System, specifically designed for early-onset scoliosis. The MARVEL Growing Rod System is a posterior stabilizing rod that can be surgically implanted and periodically lengthened through hand-operated mechanical actuation. For example, in July 2023, Globus Medical Inc., a US-based medical device company, launched the MARVEL Growing Rod System. It is designed to assist patients under 10 years old with early-onset scoliosis in achieving and maintaining spinal correction while allowing for continued growth through minimally invasive distraction. The system offers significant distraction, immediate tactile feedback, and automated locking, ensuring reliable growth. This innovative product, the Growing Rod System, is expected to contribute to the future growth of the market.

Major companies operating in the kyphoscoliosis treatment market report are Johnson & Johnson Services Inc., Aspen Medical Products LLC, Medtronic PLC, Stryker Corporation, Milwaukee Brace Company, Zimmer Biomet Holdings Inc., Perrigo Company PLC, Teva Pharmaceuticals Inc., B. Braun Melsungen Aktiengesellschaft, Aurobindo Pharma Limited, Integra LifeSciences Ltd., NuVasive Inc., DJO Global Inc., Globus Medical Inc., Boston Orthotics & Prosthetics, Ossur hf., Aesculap Inc., DeRoyal Industries Inc., MicroPort Scientific Corp., Alphatec Holdings Inc., Trulife Ltd., Ottobock SE & Co. KGaA, Orthofix Holdings Inc., OrthoPediatrics Corp., Proteor S.A., Orthomerica Products Inc., Breg Inc., Innomed Inc., Restorative Care of America Inc., Spinal Elements Inc.

North America was the largest region in the kyphoscoliosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kyphoscoliosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the kyphoscoliosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The kyphoscoliosis treatment market consists of revenues earned by entities by providing services such as physical therapy, pain management, specialist psychological support, and medical evaluation. The market value includes the value of related goods sold by the service provider or included within the service offering. The kyphoscoliosis treatment market also includes sales of lumbar support cushions, orthopedic braces, back support belts, and exercise and therapy equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Kyphoscoliosis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on kyphoscoliosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for kyphoscoliosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The kyphoscoliosis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Postural Kyphosis; Scheuermann's Kyphosis; Congenital Kyphosis
• 2) By Treatment: Medications; Surgery And Bracing
• 3) By End-User: Hospital; Clinics; Ambulatory Surgical Centers
• Subsegments:
• 1) By Postural Kyphosis: Adolescent Postural Kyphosis; Adult Postural Kyphosis
• 2) By Scheuermann's Kyphosis: Adolescent Scheuermann's Kyphosis; Adult Scheuermann's Kyphosis
• 3) By Congenital Kyphosis: Type I Congenital Kyphosis; Type II Congenital Kyphosis; Other Congenital Forms
• Companies Mentioned: Johnson & Johnson Services Inc.; Aspen Medical Products LLC; Medtronic plc; Stryker Corporation; Milwaukee Brace Company; Zimmer Biomet Holdings Inc.; Perrigo Company plc; Teva Pharmaceuticals Inc.; B. Braun Melsungen Aktiengesellschaft; Aurobindo Pharma Limited; Integra LifeSciences Ltd.; NuVasive Inc.; DJO Global Inc.; Globus Medical Inc.; Boston Orthotics & Prosthetics; Ossur hf.; Aesculap Inc.; DeRoyal Industries Inc.; MicroPort Scientific Corp.; Alphatec Holdings Inc.; Trulife Ltd.; Ottobock SE & Co. KGaA; Orthofix Holdings Inc.; OrthoPediatrics Corp.; Proteor S.A.; Orthomerica Products Inc.; Breg Inc.; Innomed Inc.; Restorative Care of America Inc.; Spinal Elements Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Kyphoscoliosis Treatment Market Characteristics

3. Kyphoscoliosis Treatment Market Trends And Strategies

4. Kyphoscoliosis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Kyphoscoliosis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Kyphoscoliosis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Kyphoscoliosis Treatment Market Growth Rate Analysis
• 5.4. Global Kyphoscoliosis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Kyphoscoliosis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Kyphoscoliosis Treatment Total Addressable Market (TAM)

6. Kyphoscoliosis Treatment Market Segmentation

• 6.1. Global Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Postural Kyphosis
• Scheuermann's Kyphosis
• Congenital Kyphosis
• 6.2. Global Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medications
• Surgery And Bracing
• 6.3. Global Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Clinics
• Ambulatory Surgical Centers
• 6.4. Global Kyphoscoliosis Treatment Market, Sub-Segmentation Of Postural Kyphosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adolescent Postural Kyphosis
• Adult Postural Kyphosis
• 6.5. Global Kyphoscoliosis Treatment Market, Sub-Segmentation Of Scheuermann's Kyphosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adolescent Scheuermann's Kyphosis
• Adult Scheuermann's Kyphosis
• 6.6. Global Kyphoscoliosis Treatment Market, Sub-Segmentation Of Congenital Kyphosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Type I Congenital Kyphosis
• Type II Congenital Kyphosis
• Other Congenital Forms

7. Kyphoscoliosis Treatment Market Regional And Country Analysis

• 7.1. Global Kyphoscoliosis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Kyphoscoliosis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Kyphoscoliosis Treatment Market

• 8.1. Asia-Pacific Kyphoscoliosis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Kyphoscoliosis Treatment Market

• 9.1. China Kyphoscoliosis Treatment Market Overview
• 9.2. China Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Kyphoscoliosis Treatment Market

• 10.1. India Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Kyphoscoliosis Treatment Market

• 11.1. Japan Kyphoscoliosis Treatment Market Overview
• 11.2. Japan Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Kyphoscoliosis Treatment Market

• 12.1. Australia Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Kyphoscoliosis Treatment Market

• 13.1. Indonesia Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Kyphoscoliosis Treatment Market

• 14.1. South Korea Kyphoscoliosis Treatment Market Overview
• 14.2. South Korea Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Kyphoscoliosis Treatment Market

• 15.1. Western Europe Kyphoscoliosis Treatment Market Overview
• 15.2. Western Europe Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Kyphoscoliosis Treatment Market

• 16.1. UK Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Kyphoscoliosis Treatment Market

• 17.1. Germany Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Kyphoscoliosis Treatment Market

• 18.1. France Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Kyphoscoliosis Treatment Market

• 19.1. Italy Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Kyphoscoliosis Treatment Market

• 20.1. Spain Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Kyphoscoliosis Treatment Market

• 21.1. Eastern Europe Kyphoscoliosis Treatment Market Overview
• 21.2. Eastern Europe Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Kyphoscoliosis Treatment Market

• 22.1. Russia Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Kyphoscoliosis Treatment Market

• 23.1. North America Kyphoscoliosis Treatment Market Overview
• 23.2. North America Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Kyphoscoliosis Treatment Market

• 24.1. USA Kyphoscoliosis Treatment Market Overview
• 24.2. USA Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Kyphoscoliosis Treatment Market

• 25.1. Canada Kyphoscoliosis Treatment Market Overview
• 25.2. Canada Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Kyphoscoliosis Treatment Market

• 26.1. South America Kyphoscoliosis Treatment Market Overview
• 26.2. South America Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Kyphoscoliosis Treatment Market

• 27.1. Brazil Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Kyphoscoliosis Treatment Market

• 28.1. Middle East Kyphoscoliosis Treatment Market Overview
• 28.2. Middle East Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Kyphoscoliosis Treatment Market

• 29.1. Africa Kyphoscoliosis Treatment Market Overview
• 29.2. Africa Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Kyphoscoliosis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Kyphoscoliosis Treatment Market Competitive Landscape
• 30.2. Kyphoscoliosis Treatment Market Company Profiles
  • 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Aspen Medical Products LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Milwaukee Brace Company Overview, Products and Services, Strategy and Financial Analysis

31. Kyphoscoliosis Treatment Market Other Major And Innovative Companies

• 31.1. Zimmer Biomet Holdings Inc.
• 31.2. Perrigo Company plc
• 31.3. Teva Pharmaceuticals Inc.
• 31.4. B. Braun Melsungen Aktiengesellschaft
• 31.5. Aurobindo Pharma Limited
• 31.6. Integra LifeSciences Ltd.
• 31.7. NuVasive Inc.
• 31.8. DJO Global Inc.
• 31.9. Globus Medical Inc.
• 31.10. Boston Orthotics & Prosthetics
• 31.11. Ossur hf.
• 31.12. Aesculap Inc.
• 31.13. DeRoyal Industries Inc.
• 31.14. MicroPort Scientific Corp.
• 31.15. Alphatec Holdings Inc.

32. Global Kyphoscoliosis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Kyphoscoliosis Treatment Market

34. Recent Developments In The Kyphoscoliosis Treatment Market

35. Kyphoscoliosis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Kyphoscoliosis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Kyphoscoliosis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Kyphoscoliosis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer